Pages that link to "Q54432578"

The following pages link to Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial. (Q54432578):

Displaying 25 items.

• Oral antiplatelet therapy for acute ischaemic stroke (Q24197866) (← links)
• Antiplatelet therapy for carotid artery stenting (Q26852304) (← links)
• Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis (Q28076042) (← links)
• Improved thrombolytic effect with focused ultrasound and neuroprotective agent against acute carotid artery thrombosis in rat. (Q30356179) (← links)
• Research on intracranial atherosclerosis from the East and west: why are the results different? (Q34357545) (← links)
• Quantification of errors in ordinal outcome scales using shannon entropy: effect on sample size calculations (Q34826078) (← links)
• The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis (Q34995043) (← links)
• RETRACTED: Systematic study of cilostazol on secondary stroke prevention: a meta-analysis (Q35061792) (← links)
• Nitric oxide: considerations for the treatment of ischemic stroke (Q36079329) (← links)
• Update on selecting and adjusting antiplatelet therapy for prevention of noncardiogenic, recurrent ischemic stroke (Q37943864) (← links)
• Use of Cilostazol for Secondary Stroke Prevention: An Old Dog with New Tricks? (Q37986922) (← links)
• The Effectiveness and Safety of Triple‐Antiplatelet Treatment Based on Cilostazol for Patients Receiving Percutaneous Coronary Intervention: A Meta‐Analysis (Q38010134) (← links)
• Clinical efficacy and safety of cilostazol: a critical review of the literature (Q38372990) (← links)
• Meta-Analysis of Studies Evaluating the Effect of Cilostazol on Major Outcomes After Carotid Stenting (Q38653643) (← links)
• Comparative Efficacy and Safety of Nine Anti-Platelet Therapies for Patients with Ischemic Stroke or Transient Ischemic Attack: a Mixed Treatment Comparisons (Q40023249) (← links)
• Cilostazol improves endothelial function in acute cerebral ischemia patients: a double-blind placebo controlled trial with flow-mediated dilation technique. (Q41558315) (← links)
• Thrombectomy for delayed basilar stent occlusion with good outcome (Q41954112) (← links)
• Clopidogrel loading dose versus maintenance dose to treat patients with acute ischaemic stroke in China (CLASS-China): results from a prospective double-blind randomised clinical trial (Q42279148) (← links)
• Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbi (Q42690507) (← links)
• Effect of cilostazol in the treatment of acute ischemic stroke in the lenticulostriate artery territory (Q43914580) (← links)
• Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting. (Q53118529) (← links)
• Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction. (Q55003714) (← links)
• Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial (Q57216023) (← links)
• Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset (Q92196431) (← links)
• Comparison of long-term efficacy and safety between cilostazol and clopidogrel in chronic ischemic stroke: a nationwide cohort study (Q98726681) (← links)